Patents Examined by Robert J Yamasaki
  • Patent number: 9993507
    Abstract: The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial consortia, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial consortia, and compositions comprising the same, in methods for modulating the production and yield of milk and milk components in ruminants. In particular aspects, the disclosure provides methods of increasing desirable components of milk in ruminants. Furthermore, the disclosure provides for methods of modulating the rumen microbiome.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: June 12, 2018
    Assignee: Ascus Biosciences, Inc.
    Inventors: Mallory Embree, Luke Picking, Grant Gogul, Janna Tarasova
  • Patent number: 9995736
    Abstract: The present disclosure provides a nucleated red blood cell simulating particle, which may be leukocytes bound to a fluorescent-staining inhibitor capable of stably binding to the nucleus or a nucleic acid in a cell so as to reduce the binding capacity of the particles to a fluorescent dye during their detection. The present disclosure also provides a method for preparing nucleated red blood cell simulating particles, including the following steps: (a) obtaining purified leukocytes; (b) suspending the leukocytes in a cell treatment solution containing a fluorescent-staining inhibitor which stably binds to the nucleus or a nucleic acid in a cell, and (c) washing the obtained product. The present disclosure also provides a hematology control mixture containing the nucleated red blood cell simulating particles.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: June 12, 2018
    Assignee: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    Inventors: Cheng Deng, Zuyue Xu, He Liu
  • Patent number: 9989519
    Abstract: The invention provides methods for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension RLD.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: June 5, 2018
    Assignee: Clayton Pharmaceuticals, LLC
    Inventors: Siddhartha Bhoopathy, Indranil Nandi, Ami C. Patel, Ismael J. Hidalgo
  • Patent number: 9987316
    Abstract: A method for controlling detrimental oral organisms in various individuals includes administering a priobiotic composition that includes one or more species or strains of beneficial fungi and/or one or more compounds produced therefrom that control one or more species of detrimental oral bacteria and/or other organisms.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: June 5, 2018
    Assignee: Case Western Reserve University
    Inventors: Mahmoud A. Ghannoum, Pranab Mukherjee
  • Patent number: 9968681
    Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: May 15, 2018
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Nantes, CHU Nantes
    Inventors: Pierre Weiss, Eva Mathieu, Jérôme Guicheux, Patricia Lemarchand
  • Patent number: 9970041
    Abstract: The present invention relates to a procedure for the production of tiacumicin B comprising fermentation of a micro-organism capable of producing tiacumicin B, in particular of the species Dactylosporangium aurantiacum or Actinoplanes deccanensis, in a culture broth containing emulsifiers, such as ethoxylated castor oil, in combination with antifoaming products and vegetable oils.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: May 15, 2018
    Assignee: OLON S.P.A.
    Inventors: Guido Trione, Antonella Malcangi
  • Patent number: 9963730
    Abstract: Provided herein are methods for processing biomass materials that are disposed in one or more structures or carriers, e.g., a bag, a shell, a net, a membrane, a mesh or any combination of these. Containing the material in this manner allows it to be readily added or removed at any point and in any sequence during processing.
    Type: Grant
    Filed: May 16, 2017
    Date of Patent: May 8, 2018
    Assignee: XYLECO, INC.
    Inventors: Marshall Medoff, Thomas Craig Masterman, James Lynch
  • Patent number: 9962466
    Abstract: The invention is directed to methods and compositions for obtaining uniform sized muscle fiber fragments for transplantation. These muscle fiber fragments are able to reconstitute into long fibers that are oriented along native muscle. The implanted muscle cells integrate with native vascular and neural network, as confirmed by histology and immunohistochemistry. This invention is particularly advantageous because autologous muscle can be harvested from a donor site, processed and injected into target sites in the operating room. The fragmented muscle fibers can be readily integrated within the host.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: May 8, 2018
    Assignee: Wake Forest University Health Sciences
    Inventors: Anthony Atala, James Yoo, In Kap Ko
  • Patent number: 9949474
    Abstract: A composition and method for generating reagents and the composition of these reagents for the stabilization and preservation of viability of cancer tissue which has been surgically excised and the suspension and/or termination of apoptosis (cell death) by significant modulation of cell metabolism by low molar concentrations of synergistic chemistries and hormonal growth enhancers while maintaining normal gene expression patterns of the surgically excised tissue.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: April 24, 2018
    Assignee: TRUCKEE APPLIED GENOMICS, LLC
    Inventor: Tony K. Baker
  • Patent number: 9938571
    Abstract: Manufacturing methods and compositions are described for production of self-contained microfluidic cartridge devices with on-board reagents for molecular biological testing. Sensitive reagents are stored in dry form without lyophilization or freezing, and reconstituted at the point of use with either a biological sample or a sample eluate at the point of use. Manufacturing methods include sheet and roll fabrication processes where the reagents are printed in place and sealed within individual microfluidic cartridges before gel vitrification.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 10, 2018
    Assignee: Micronics, Inc.
    Inventors: C. Frederick Battrell, Denise Maxine Hoekstra, Joan Haab, John R. Williford, Sabrina N. Gunderson, Elizabeth R. Leber, Isaac Sprague
  • Patent number: 9925537
    Abstract: A microfluidic device is configured to analyze a sample of biological material. The microfluidic device includes a fluid guide structure constructed in order to divide a sample introduced into the microfluidic device into a plurality of subquantities. The microfluidic device further includes a plurality of reaction chambers each of which is fluidically connected to the fluid guide structure. Each of the reaction chambers has a filter configured to filter out target cells from the sample, and each of the reaction chambers is constructed to receive a sample subquantity. In each of the reaction chambers, a result of a reaction between a target-cell-specific active substance that is different for each of the reaction chambers and the target cells of the sample subquantity that is taken up is acquirable.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: March 27, 2018
    Assignee: Robert Bosch GmbH
    Inventor: Jochen Hoffmann
  • Patent number: 9925301
    Abstract: Provided herein relates to methods for preparing micron range silk fibers (or silk microfibers) and compositions comprising a micron range silk fiber (or a silk microfiber). The micron range silk fibers (or silk microfibers) can be used in various applications ranging from fillers in cosmetics to reinforcement materials to design high strength composites, e.g., reinforced scaffolds. In some embodiments, the silk microfiber-reinforced scaffolds can be used for bone graft applications because of their high compressive strength.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: March 27, 2018
    Assignee: TRUSTEES OF TUFTS COLLEGE
    Inventors: David L. Kaplan, Biman B. Mandal
  • Patent number: 9918479
    Abstract: Provided are compounds and compositions derived from Pseudomonas sp., particularly, Pseudomonas fluorescens or Pseudomonas protegens and more particularly strain having the identifying characteristics of Pseudomonas ATCC 55799 having antimicrobial properties and particularly, antibacterial properties.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: March 20, 2018
    Assignee: Marrone Bio Innovations, Inc.
    Inventors: Ratnakar Asolkar, Ana Lucia Cordova-Kreylos, Carly Todd
  • Patent number: 9896703
    Abstract: An object of the present invention is to provide a method in which a fat and/or oil is produced by a transesterification reaction using a lipase. Specifically, the present invention relates to a method for producing a transesterified fat and/or oil, comprising: (1) a low-temperature clay treatment step of bringing a fat and/or oil and a clay into contact with each other at 30 to 80° C. to obtain a reaction substrate; and (2) a step of subjecting the reaction substrate to a transesterification reaction in the presence of a lipase-containing composition.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: February 20, 2018
    Assignee: The Nisshin OilliO Group, Ltd.
    Inventors: Yousuke Nakamura, Yuto Nakazawa, Yuko Toyama, Yoshie Yamauchi, Hidetaka Uehara
  • Patent number: 9897613
    Abstract: Microorganisms, particularly bacteria, are identified and characterized on the basis of a mass spectrometric measurement of their protein profiles with ionization by matrix-assisted laser desorption. In order to measure the microbial resistance to antibiotics, the protein profiles of microorganisms are measured after cultivation for a short time duration in nutrient media containing the antibiotics.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: February 20, 2018
    Inventors: Vadim Markovich Govorun, Jochen Franzen
  • Patent number: 9879295
    Abstract: [Problem] To provide a bacterial cellulose which is highly dispersible in a liquid, shows excellent molding properties and high miscibility with other materials when applied to materials, and, therefore, has a high applicability as a practical material, and a bacterium which produces the bacterial cellulose. [Solution] A bacterial cellulose, water that contains said bacterial cellulose at a final concentration of 0.1±0.006 (w/w) showing a light transmittance at a wavelength of 500 nm of 35% or greater, and a bacterium producing the bacterial cellulose. According to the present invention, the bacterial cellulose that is uniformly dispersible in a liquid such as water can be obtained. The bacterial cellulose shows excellent molding properties and high miscibility with other materials and, therefore, can contribute to the improvement in the qualities of a final product or production efficiency thereof or to the reduction of production cost.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: January 30, 2018
    Inventors: Kenji Tajima, Ryota Kose